Show
Sort by
-
- Journal Article
- A1
- open access
Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT
-
Rhenium-188 based radiopharmaceuticals for treatment of liver tumours
-
Influence of iohexol on the outcome of I131 treatment in cats
-
Does iohexol one day prior to radioiodine treatment, affect absorbed dose in hyperthyroid cats?
-
Re-188-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study
-
TGF beta 1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors
-
In vitro screening for synergism of high-linear energy transfer Bi-213-radiotherapy with other therapeutic agents for the treatment of B-Cell chronic lymphocytic leukemia
-
Re-188-HDD/lipiodol for treatment of hepatocellular carcinoma: A feasibility study in patients with advanced cirrhosis
-
Optimised tracer-dependent dosage cards to obtain weight-independent effective doses
-
In vivo evaluation and dosimetry of I-123-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT in an R1M rhabdomyrosarcoma athymic mouse model